CAR-T

Participants in China’s CAR-T ‘Lymphoma Value-Based Payment Plan’ have achieved complete remission

🎗️ **Participants in China’s CAR-T ‘Lymphoma Value-Based Payment Plan’ have achieved complete remission.** 🎗️ Exciting news! Fosun Kite has just announced that the first participants in China’s “Lymphoma Value-Based Payment Plan” have achieved complete remission. These four patients, hailing from Shanghai, Guangzhou, and Hangzhou, have all reached complete remission after undergoing the innovative CAR-T cell Read More

June 11th,2024 Lymphoma , CAR-T

The Chinese medical team’s Revolutionary CAR-T Therapy: Long-lasting asthma relief with a single injection

### 🚀 The Chinese medical team’s Revolutionary CAR-T Therapy: Long-lasting asthma relief with a single injection.! 📢 Exciting news from the world of medical science! The team led by Professor Peng Min at Tsinghua University has made a groundbreaking advancement in CAR-T cell therapy. Imagine a world where chronic diseases like allergic asthma can be managed Read More

June 6th,2024 CAR-T

New Breakthrough! Chinese Medical Team’s Remarkable Results with CLDN18.2 CAR-T Therapy for Pancreatic Cancer!

“New Breakthrough! Chinese Medical Team’s Remarkable Results with CLDN18.2 CAR-T Therapy for Pancreatic Cancer! 🎉” On May 25, 2024, the Journal of Clinical Oncology (JCO) published groundbreaking research by Professor Lin Shen’s team from Peking University Cancer Hospital on the application of CLDN18.2 CAR-T cell therapy for refractory metastatic pancreatic cancer, achieving impressive outcomes! This Read More

May 29th,2024 CAR-T , Solid tumor

Key Step in Precision Treatment: Detailed Explanation of CAR-T Apheresis for a Russian Patient at Jiahui International Hospital in Shanghai

Title:     Key Step in Precision Treatment: Detailed Explanation of CAR-T Apheresis for a Russian Patient at Jiahui International Hospital in Shanghai Content:      Vladimir Borzenkov, a 68-year-old Russian patient from Saint Petersburg, recently underwent a crucial step in CAR-T therapy at Jiahui International Hospital in Shanghai – apheresis. This process involves collecting Read More

May 24th,2024 patient story , CAR-T

International Standards for Innovative Medical Services: The Initial Experience of Singaporean Patients at Jiahui International Hospital

Title: International Standards for Innovative Medical Services: The Initial Experience of Singaporean Patients at Jiahui International Hospital   Content: Singaporean patient, Ms. Teresa, recently experienced unique CAR-T therapy at Jiahui International Hospital in Shanghai. From scheduling to consultation, Jiahui Hospital demonstrated its top-notch service and medical expertise. During her initial visit, Teresa was impressed by Read More

May 20th,2024 CAR-T , patient story

Historic Moment! Chinese Medical Team Successfully Cures Diabetes Patient

**Historic Moment! Chinese Medical Team Successfully Cures Diabetes Patient** In an exhilarating milestone moment, China’s medical technology has reached new heights! In a groundbreaking technological breakthrough, a Chinese medical team has successfully cured the world’s first case of type 2 diabetes through autologous regenerated pancreatic islet transplantation, marking a tremendous success in diabetes treatment! The Read More

May 11th,2024 CAR-T

 Exploring CAR-T Therapy: Advantages and Challenges

 Exploring CAR-T Therapy: Advantages and Challenges   CAR-T therapy, as an emerging immunotherapy approach, is gradually attracting attention. Its advantages in the field of cancer treatment bring hope, yet it also faces challenges that need to be overcome. ### Advantages: **1. Powerful Antitumor Effect:**     CAR-T therapy modifies a patient’s T cells to enhance Read More

May 9th,2024 CAR-T

Exploring China’s Indigenous Drug Anlotinib: A Beacon of Hope for Digestive Tract Tumor Patients

Exploring China’s Indigenous Drug Anlotinib: A Beacon of Hope for Digestive Tract Tumor Patients   In the continuous advancement of medicine, Anlotinib combined chemotherapy is emerging as a frontline therapy for advanced, unresectable liver metastases from digestive tract tumors. Let’s delve into the latest findings from a phase II clinical trial initiated by researchers from Read More

May 6th,2024 CAR-T

🔬✨ Overall Response Rate 50%! Chinese Research Entity’s Solid Tumor CAR-T Hits Colorectal Cancer

🔬✨ Overall Response Rate 50%! Chinese Research Entity’s Solid Tumor CAR-T Hits Colorectal Cancer #Solidtumor In the journey to conquer cancer, a significant breakthrough is stirring! Shanghai Sundise Biotech has successfully developed the first candidate product GCC19CART, based on its independently developed CoupledCAR® platform technology. This innovative autologous #CART therapy product is specifically designed to Read More

April 25th,2024 CAR-T

2024 AACR | China’s Innovative Medicine Leads Globally! Dazzling International with Multi-Cancer Research Achievements

2024 AACR | China’s Innovative Medicine Leads Globally! Dazzling International with Multi-Cancer Research Achievements #AACR This month, the annual cancer research summit, #AACR, arrived in San Diego, USA! Focused on #tumor research and innovation, top global achievements were fully showcased. Under China’s Biopharmaceuticals, the new drug, Anlotinib from Zhongda Tianqing, shines brightly! Latest Research Progress Read More

April 24th,2024 CAR-T

AACR 2024/Breakthrough Chinese Research – Monotherapy for Late-stage #SolidTumors and #Lymphomas

AACR 2024/Breakthrough Chinese Research – Monotherapy for Late-stage #SolidTumors and #Lymphomas #AACR2024 At the 2024 American Association for Cancer Research (#AACR) Annual Meeting, innovative drugs from China showed promising safety and preliminary efficacy in early clinical trials, attracting high interest from attending experts and researchers, showcasing the strength of #Chineseresearch teams in new drug development. Read More

April 22nd,2024 CAR-T

AACR 2024/Breakthrough in Treating Recurrent or Metastatic Nasopharyngeal Carcinoma by Chinese Medical Team

AACR 2024/Breakthrough in Treating Recurrent or Metastatic Nasopharyngeal Carcinoma by Chinese Medical Team We’re thrilled to share groundbreaking updates from the 2024 American Association for Cancer Research (AACR) Annual Meeting! China’s innovative pharmaceuticals are making waves in early clinical trials, hinting at promising breakthroughs in cancer treatment! At the forefront is the remarkable research on Read More

April 19th,2024 CAR-T